We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MICC:EURONEXT AMSTERDAMMagnum Ice Cream Co. N.V. Analysis

Data as of 2026-06-03 - not real-time

$16.76

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The Magnum Ice Cream Company trades at $16.76, just above its 20‑day SMA of $15.75 and comfortably under the resistance level of $17.03, while the MACD remains bullish and the RSI sits at 63, indicating modest upward momentum but approaching overbought territory. Revenue has slipped 4.1% year‑over‑year to €7.91 bn, yet Q1 2026 delivered a 4.5% organic sales lift and the company reaffirmed its FY guidance, suggesting the recent dip may be temporary. Valuation metrics are mixed: a trailing P/E of 29.9 contrasts sharply with a forward P/E of 13.1 and a price‑to‑sales ratio of 1.30, while the DCF‑derived fair value of $3.02 implies the market may be overpricing the stock, though the modest 4.5% upside estimate aligns price with intrinsic expectations. The balance sheet is heavily leveraged, with a debt‑to‑equity ratio above 500 and a net debt position exceeding €3 bn, raising concerns despite a low beta of 0.62 and a defensive consumer‑goods profile. Overall, the stock sits at a crossroads where short‑term technical signals are positive, fundamental growth is modest, and financial risk remains elevated.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above 20‑day SMA
  • Decreasing volume and RSI near overbought
  • High leverage and elevated P/E ratio

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Q1 2026 organic sales growth of 4.5%
  • Forward P/E compression to 13.1 and analyst median target ~€17.6
  • Defensive consumer‑staples positioning

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong brand portfolio (Magnum, Ben & Jerry's, Cornetto, Wall's)
  • Persistent high debt burden limiting financial flexibility
  • Stable demand in consumer defensive sector despite macro volatility

Key Metrics & Analysis

Financial Health

Revenue Growth-4.10%
Profit Margin3.70%
P/E Ratio29.9
ROE17.88%
ROA8.72%
Debt/Equity539.65
P/B Ratio14.2
Op. Cash Flow$483.0M
Free Cash Flow$365.6M

Technical Analysis

TrendNeutral
RSI63.3
Support$14.57
Resistance$17.03
MA 20$15.75
MA 50$14.85
MA 200$15.64
MACDBullish
VolumeDecreasing
Fear & Greed Index92.54

Valuation

Fair Value$3.02
Target Price$17.53
Upside/Downside4.56%
GradeFair
TypeBlend

Risk Assessment

Beta0.62
Volatility58.76%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.